title: Synthesis and characterization of the colistin peptide polymyxin E1 and related antimicrobial peptides.
abstract: Two strategies were developed to synthesize the acylated cyclic peptides know as polymyxins. Synthesis of polymyxin E1 and several analogs enabled us to evaluate the minimum inhibitory concentration of individual compounds against Gram-negative bacteria. In this study we also report the first identification of two component peptides in the complex polymyxin fermentation product colistin, a Thr2Ser isoform and an acyl group isomer. Both of these peptides, as well as a known component peptide, Leu7Ile, were similar to polymyxin E1 in potency, suggesting that conservative mutations in the colistin family are functionally inconsequential. In contrast, the acyclic analogs of all of these peptides were inactive, indicating that the characteristic lariat structure of the polymyxins is necessary for antimicrobial activity.
authors: PathoGenesis Corporation, Seattle, Washington 98119, USA. tkline@pathogenesis.com
authors: T
authors: T
authors: Kline
authors: D
authors: D
authors: Holub
authors: J
authors: J
authors: Therrien
authors: T
authors: T
authors: Leung
authors: D
authors: D
authors: Ryckman
mesh_terms: D000900:Anti-Bacterial Agents / Q000138:chemical synthesis* / Q000494:pharmacology*; D001671:Biochemistry / Q000379:methods; D003091:Colistin / Q000138:chemical synthesis* / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical; D006090:Gram-Negative Bacteria / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D010456:Peptides, Cyclic / Q000138:chemical synthesis; D020033:Protein Isoforms; D013329:Structure-Activity Relationship
chemical_list: D000900:Anti-Bacterial Agents; D010456:Peptides, Cyclic; D020033:Protein Isoforms; D003091:Colistin